IBIO

iBio, Inc.

1.29 USD
+0.09 (+7.54%)
Last updated
This page is just a preview of the data found in TrendSpider’s full version

iBio, Inc. stock is up 12.17% since 30 days ago. The next earnings date is May 13, 2024. The company has had above-average volume in the last 30 days. Its seasonality going into this month shows a chance of a green month, as 57.14% of the previous 13 February’s closed higher than January.

About iBio, Inc.

iBio, Inc. provides contract development and manufacturing services to collaborators and third-party customers in the United States. The company operates in two segments: Biopharmaceuticals and Bioprocessing. Its lead therapeutic candidate is IBIO-100 that is being advanced for investigational new drug development for the treatment of systemic scleroderma and idiopathic pulmonary fibrosis.